Irradiation with ultrasound of low output intensity increased chemo sensitivity of subcutaneous solid tumors to an anti-cancer agent

被引:53
作者
Tomizawa, M
Ebara, M
Saisho, H
Sakiyama, S
Tagawa, M
机构
[1] Chiba Canc Res Inst, Div Pathol, Chuo Ku, Chiba 2608670, Japan
[2] Chiba Univ, Grad Sch Med, Dept Med & Clin Oncol, Chuo Ku, Chiba 2608670, Japan
[3] Chiba Canc Ctr, Res Inst, Chuo Ku, Chiba 2608717, Japan
基金
日本学术振兴会;
关键词
electroporation; ultrasound; drug delivery; gene delivery;
D O I
10.1016/S0304-3835(01)00687-5
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Ultrasound is a possible mechanical method to deliver small molecules into target cells. In order to evaluate the therapeutic potentials provided by ultrasound irradiation, we compared anti-tumor effects of electroporation-and ultrasound-mediated chemotherapy and efficacy of gene transfer by the two methods. Electric pulses (5 Hz, 100 V/cm, 8 square-wave/100 mu sec) or ultrasound (1 MHz, 2 W/cm(2), 5 min) was delivered to subcutaneous solid tumors of murine lymphoma after the tumor-bearing mice received an intraperitoneal injection of bleomycin (BLM) (2.5 mg) or intratumoral injection of plasmid DNA containing the luciferase reporter gene, Administration of BLM alone did not affect the subsequent tumor growth but additive treatment with ultrasound irradiation suppressed the growth to the same level as electroporation. The luciferase activity of the DNA-injected tumors showed that ultrasound irradiation achieved better transfection efficiency than plasmid DNA injection alone but the efficacy was not as great as that by electroporation. The low energy level of ultrasound that is Currently used for a diagnostic purpose and physical therapy in clinical fields can thereby increase the in vivo chemosensitivity of treated tumors but further modifications are necessary to achieve better efficacy of the ultrasound-mediated gene transfer. (C) 2001 Elsevier Science Ireland Ltd. All rights reserved.
引用
收藏
页码:31 / 35
页数:5
相关论文
共 23 条
[1]   Ultrasound enhancement of cationic lipid-mediated gene transfer to primary tumors following systemic administration [J].
Anwer, K ;
Kao, G ;
Proctor, B ;
Anscombe, I ;
Florack, V ;
Earls, R ;
Wilson, E ;
McCreery, T ;
Unger, E ;
Rolland, A ;
Sullivan, SM .
GENE THERAPY, 2000, 7 (21) :1833-1839
[2]  
BELEHRADEK M, 1993, CANCER-AM CANCER SOC, V72, P3694, DOI 10.1002/1097-0142(19931215)72:12<3694::AID-CNCR2820721222>3.0.CO
[3]  
2-2
[4]   ANTITUMOR EFFECT OF PSK AT A DISTANT SITE - TUMOR-SPECIFIC IMMUNITY AND COMBINATION WITH OTHER CHEMOTHERAPEUTIC-AGENTS [J].
EBINA, T ;
MURATA, K .
JAPANESE JOURNAL OF CANCER RESEARCH, 1992, 83 (07) :775-782
[5]   Highly efficient electro-gene therapy of solid tumor by using an expression plasmid for the herpes simplex virus thymidine kinase gene [J].
Goto, T ;
Nishi, T ;
Tamura, T ;
Dev, SB ;
Takeshima, H ;
Kochi, M ;
Yoshizato, K ;
Kuratsu, J ;
Sakata, T ;
Hofmann, GA ;
Ushio, Y .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2000, 97 (01) :354-359
[6]   Electrically mediated plasmid DNA delivery to hepatocellular carcinomas in vivo [J].
Heller, L ;
Jaroszeski, MJ ;
Coppola, D ;
Pottinger, C ;
Gilbert, R ;
Heller, R .
GENE THERAPY, 2000, 7 (10) :826-829
[7]  
Horiuchi A, 2000, INT J CANCER, V88, P640, DOI 10.1002/1097-0215(20001115)88:4<640::AID-IJC19>3.0.CO
[8]  
2-K
[9]   Ultrasound-mediated transfection of mammalian cells [J].
Kim, HJ ;
Greenleaf, JF ;
Kinnick, RR ;
Bronk, JT ;
Bolander, ME .
HUMAN GENE THERAPY, 1996, 7 (11) :1339-1346
[10]  
Kuriyama S, 1999, INT J ONCOL, V14, P321